Clearly, equipment suppliers are increasingly important to drug owners and developers, as are their perceptions of companies who can help them achieve their goals.
To measure the perception that equipment purchasing and specifying managers have of the industry’s leading equipment suppliers, Nice Insight study respondents were asked to compare and evaluate 40 respective companies based on their perceptions of the following drivers: Process Integrity, Customer Service, Total Cost of Ownership, Overall Equipment Efficiency, Post-Sales Support, and Reliability. Those key equipment-supplier perception drivers, once individually rated, tabulated and averaged, create Nice Insight’s Customer Perception (CP) Score. Equipment and system suppliers with the highest Nice Insight CP scores are perceived as leaders and rank among the industry’s most reputable companies.
Primary Packaging
1 Bosch Packaging Technology 86.33% Overall CP Score
2 Bausch & Stroebel 81.17%
3 EMD Millipore 81.17%
4 Optima Pharma 81.00%
5 Telstar Life Science 80.17%
Secondary Packaging
1 Bosch Packaging Technology 86.17%
2 Thermo Fisher Scientific 82.83%
3 Bausch & Stroebel 81.17%
4 GEA 79.50%
5 Korber Solutions 79.33%
5 IMA Pharma 79.33%
Bioprocessing: Downstream
1 Bosch Packaging Technology 86.33%
2 Bausch & Stroebel 81.17%
3 EMD Millipore 81.17%
4 Optima Pharma 81.00%
5 Telstar Life Science 80.17%
Bioprocessing: Upstream
1 Bosch Packaging Technology 86.17%
2 Thermo Fisher Scientific 82.83%
3 Bausch & Stroebel 81.17%
4 GEA 79.50%
5 Korber Solutions 79.33%
5 IMA Pharma 79.33%
Liquid Processing
1 Bosch Packaging Technology 86.33%
2 Thermo Fisher Scientific 81.17%
3 Bausch & Stroebel 81.17%
4 GEA 81.00%
5 Korber Solutions 80.17%
5 IMA Pharma 80.17%
Semi-Solid Processing
1 Bosch Packaging Technology 86.33%
2 Bausch & Stroebel 81.17%
2 EMD Millipore 81.17%
4 Optima Pharma 81.00%
5 Telstar Life Science 80.17%
Solid Processing
1 Bosch Packaging Technology 86.17%
2 Thermo Fisher Scientific 82.83%
3 Bausch & Stroebel 81.17%
4 GEA 79.50%
5 Korber Solutions 79.33%
5 IMA Pharma 79.33%
